Versions Compared

Version Old Version 3 New Version Current
Changes made by

Former user

Former user

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image RemovedImage Added



Welcome 

This page describes the scope and remit of the

Steering Board for

Good Programming Practices project team in health and life sciences.


Mission
  1. To promote, develop and share Good Programming Practice within Healthcare and Life Sciences software development
  2. To develop formal guidelines for Good Programming Practice that can be used for

A basis for code development and code reviews within Healthcare

programmingSupporting

programming. Supporting development (providing standards for development) of central code repositories. ​A standard for exchange of code between organisations (Contracted code or between Sponsors and regulators)

  1. Maintain awareness of
GPP
  1. Good Programming Practice in the programming community.


Objectives
  1. Present and promote GPP Good Programming Practice work at conferences
  2. Drive discussion of 4 GPP Good Programming Practice topics this year through discussion forums etc. in order to raise awareness of GPP Good Programming Practice and to improve available documentation of GPPGood Programming Practice
  3. Establish the GPP board project as an active and integral group on the PhUSE Wikipart of PHUSE
  4. Maintain an active team of about 10 members


Activity 

Study on Good Programming Practices

  • A lot of organisations have
GPP
  • Good Programming Practice guidelines and many programmers promote them, but what happens in practice? We are developing a study to find out to what extent
GPP

Conference presentations


Publications
PhUSE

PHUSE 2009

[

Industry Standard Good Programming Practice for Clinical Trials

(Using SAS)

Pharmasug

PharmaSUG 2011

[

Good Programming Practices in Healthcare Creating Robust Programs


Steering Board Project Members

Mark Foxwell Chair, PRA, UKmailto:foxwellmark@praintl.com

Shafi Chowdhury Shafi Consultancy

Beate Hientzsch HMS analytical, Germany

Maria Dalton GSK, US

Gayathri Kolandaivelu Janssen R&D (J&J)Research & Development, US

Jane Marrer MSD, US

Ninan Luke Pfizer, India